Advertisement

Topics

CORRECTING AND REPLACING: Clinigen Signs Exclusive Supply Agreements in Global Access With Mitsubishi Tanabe, Shionogi and Romark

12:01 EDT 22 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
The fifth paragraph of release dated June 21, 2017 07:00 AM BST should read: "Under this new agreement, Idis GA will supply and distribute argatroban on an exclusive, unlicensed, on demand basis in all countries where there is n...

Other Sources for this Article

Clinigen Group plc
Shaun Chilton, Group Chief Executive Officer
Steve Glass, Chief Commercial Officer
(North America and Europe)
Tel: +44 (0) 1283 495 010
or
Instinctif Partners
Melanie Toyne-Sewell / Alex Shaw
Email: clinigen@instinctif.com
Tel: +44 (0) 20 7457 2020

NEXT ARTICLE

More From BioPortfolio on "CORRECTING AND REPLACING: Clinigen Signs Exclusive Supply Agreements in Global Access With Mitsubishi Tanabe, Shionogi and Romark"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...